Japanese drugmaker Takeda has signed a three-year agreement with the Biotechnology Industry Research Assistance Council (BIRAC) to extend advisory and mentoring support to innovators and entrepreneurs, assisting them from ideation to market deployment of healthcare solutions.
A Memorandum of Understanding (MoU) was signed by the two towards this at the ongoing Global Bio-India 2023, organised by the Centre’s Department of Biotechnology (DBT)and BIRAC ( a public sector enterprise under DBT). Last week, the BIRAC chief told businessline that they were willing to hand-hold companies and start-ups looking to participate in India’s biotechnology journey and spur further innovation.
Sanjay Patel, Global Head of Data Digital and Technology Innovation Capability Solutions, Takeda Pharmaceuticals International AG, said, “ The entrepreneurial spirit of domestic healthcare start-ups has the power to drive healthcare advancements not only in India but globally.” Serina Fischer, General Manager, Takeda Biopharmaceuticals India, added that the partnership served as a practical blueprint, highlighting how public and private players can join forces to propel substantial and enduring advances in healthcare.”
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.